EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Concurrent MLL-AF4+ infant ALL in monozygotic twins: a case report

Chenghui Li, Xin Tong, Jinfeng Yang, Hui Gao, Zhong Li

Frontiers in Pediatrics · 25.03.2026 · 14

DOI: 10.3389/fped.2026.1777726 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Pediatrics, online erschienen am 25.03.2026. Verfasst von Chenghui Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dalian Women and Children's Medical Group, Hematology-Oncology Department, Dalian, Liaoning, China. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute lymphoblastic leukemia (ALL) is the most common malignancy in childhood, but it is relatively rare in infants. However, infant ALL exhibits distinct biological characteristics and an aggressive course, with a high proportion of cases involving MLL gene rearrangements (particularly the MLL-AF4 fusion gene). Leukemia driven by MLL-AF4 is extremely rare across all populations but represents a critical and poor-prognosis subtype within infant ALL.ALL driven by the MLL-AF4 fusion is exceptionally rare and particularly fulminant. We report monochorionic monozygotic twins who presented simultaneously with MLL-AF4 positive ALL. Both neonates exhibited fever, pallor, hepatosplenomegaly and extreme leucocytosis. After achieving complete remission with the St.Jude Total Therapy XV (TOTXV) protocol, the twins experienced molecular relapse and were successfully rescued with sequential CD19- and CD22-directed CAR-T-cell therapy. Owing to parental preference and financial constraints, neither patient proceeded to allogeneic haematopoietic stem-cell transplantation; instead, they received consolidative chemotherapy. At 8 years of age, both children remain in sustained molecular remission and enjoy age-appropriate development. This concordant twin pair illustrates the natural history of MLL-AF4-positive infant ALL, supports the curative potential of CAR-T-cell therapy in this ultra-high-risk population, and emphasises the importance of prolonged molecular surveillance.

Schlagwörter

Stichwörter der Autor:innen

CAR-TMLL-AF4acute lymphoblastic leukaemiainfantsmonozygotic twins

Autor:innen und Institutionen

  • Dalian Women and Children's Medical Group, Hematology-Oncology Department, Dalian, Liaoning, China.
  • Dalian Women and Children's Medical Group, Department of Pharmacy, Dalian, Liaoning, China.

Zitieren

APA

Li, C., Tong, X., Yang, J., Gao, H., & Li, Z. (2026). Concurrent MLL-AF4+ infant ALL in monozygotic twins: a case report. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1777726

Vancouver

Li C, Tong X, Yang J, Gao H, Li Z. Concurrent MLL-AF4+ infant ALL in monozygotic twins: a case report. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1777726

BibTeX
@article{Li2026,
  author = {Li, Chenghui and Tong, Xin and Yang, Jinfeng and Gao, Hui and Li, Zhong},
  title = {Concurrent MLL-AF4+ infant ALL in monozygotic twins: a case report},
  journal = {Frontiers in Pediatrics},
  year = {2026},
  volume = {14},
  doi = {10.3389/fped.2026.1777726}
}
Kostenlos starten →